20% off during October with code SRP2020% OFF DURING OCTOBER
SRP Peptide Pre-Workout frontSRP Peptide Pre-Workout back
COMING SOONPEPTIDE PRE-WORKOUTPRE-ORDER
Free GHK-Cu 100 mg vial with every order through October 11. Click for details. FREE 100 MG VIAL WITH EVERY ORDERSee gift details →
Wolverine Blend BPC-157 and TB-500 research pathways, evidence limitations, and safety chart. HOW WOLVERINE BLEND WORKS Explore Wolverine Blend →
Items in shopping cart:
SRP RESEARCH PULSE

Products are color coded by category

← Return to the Research Vault

Brain & sleep · Compound guide

Cortexin Research Guide

Explore the mechanisms, study findings and evidence limits behind this research topic.

Product artwork identifies the SRP listing. It does not demonstrate safety or clinical benefit. The evidence guide and its sources follow below.

View product label and documentation →
Cortexin
Explore the mechanism chartCortexin mechanism chart

Mechanistic illustration. Interpret alongside the evidence and limitations below.

Back to the Research Compound Library

Human studies of a specific complex preparation

Evidence reviewed September 13, 2026.

Research overview and identity

Cortexin is studied as a peptide-containing biological preparation rather than a single sequence-defined peptide. Its evidence must be interpreted at the preparation level, with attention to manufacturing and formulation. It is not Cortagen.

Mechanism under investigation

Published studies investigate neurological outcomes and proposed cytoprotective activity. For a complex preparation, a clinical outcome cannot be assigned to one peptide or one receptor without separate experiments that identify and test that component.

What the studies report

A 2014 multicenter, placebo-controlled study enrolled 272 patients with ischemic stroke and reported favorable outcomes with Cortexin as part of treatment. A later study of 490 patients compared intravenous and intramuscular formulations. Both groups received active Cortexin; placebo injections masked the route, so that study is not a comparison of Cortexin against no active drug. [1] [2]

Limits of the evidence

A favorable abstract does not resolve all questions about trial methods, independent replication, disability outcomes or long-term safety. The studies concern their specified clinical preparations and populations. They cannot certify that an SRP research vial has equivalent composition, clinical effects or suitability for patient care.

Matching research material to a paper

Check the material identity, formulation and analytical methods against the study methods. A product name or milligram amount alone does not demonstrate experimental equivalence. Published research does not establish the identity, purity or potency of a retail batch; batch-specific analytical documentation must be assessed separately.

For laboratory research only. Not for human or veterinary use. This guide is educational and contains no dosing, reconstitution or administration instructions.

Sources and further reading

  1. Aliferova et al. — multicenter placebo-controlled ischemic-stroke study (2014)
  2. Cortexin dosage-form comparison — 490-patient study

Related catalogue listing

Cortexin product information

Scroll to Top
View Cart